Showing results (21-30 of 50) with videos related to
Sort By:
Pageof 5
Scientific Reports|January 16, 2015
Identification of molecular signature of head and neck cancer stem-like cellsShubham Shrivastava, Robert Steele, Melanie Sowadski, et al.Immunity, Inflammation and Disease|January 16, 2021
Disease-duration based comparison of subsets of immune cells in SARS CoV-2 infected patients presenting with mild or severe symptoms identifies prognostic markers for severityArchana Kulkarni-Munje, Sonali Palkar, Shubham Shrivastava, et al.The American Journal of Pathology|January 19, 2016
Serum miR-30e and miR-223 as Novel Noninvasive Biomarkers for Hepatocellular CarcinomaSourav Bhattacharya, Robert Steele, Shubham Shrivastava, et al.Journal of Virology|September 3, 2010
Hepatitis C virus infection impairs IRF-7 translocation and Alpha interferon synthesis in immortalized human hepatocytesAmit Raychoudhuri, Shubham Shrivastava, Robert Steele, et al.Transactions of the Royal Society of Tropical Medicine and Hygiene|June 3, 2020
Correlation of serostatus and viraemia levels among Indian dengue patients at the time of first diagnosisRuta Kulkarni, Shubham Shrivastava, Harshad P Patil, et al.NPJ Vaccines|July 31, 2020
Sequential immunization induces strong and broad immunity against all four dengue virus serotypesJue Hou, Shubham Shrivastava, Hooi Linn Loo, et al.Journal of Medical Economics|January 27, 2021
Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarinDejan Milentijevic, Jennifer H Lin, Yen-Wen Chen, et al.The American Journal of Tropical Medicine and Hygiene|June 17, 2021
Early and High SARS-CoV-2 Neutralizing Antibodies Are Associated with Severity in COVID-19 Patients from IndiaShubham Shrivastava, Sonali Palkar, Jignesh Shah, et al.Journal of Virology|November 20, 2015
Knockdown of Autophagy Inhibits Infectious Hepatitis C Virus Release by the Exosomal PathwayShubham Shrivastava, Pradip Devhare, Nanthiya Sujijantarat, et al.American Heart Journal|March 1, 2020
Rivaroxaban versus warfarin in patients with nonvalvular atrial fibrillation and stage IV-V chronic kidney diseaseMatthew R Weir, Veronica Ashton, Kenneth T Moore, et al.Pageof 5